ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy

Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

(2011) Y. Matloub et al.   BLOOD

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

(2010) V. Conter et al.   BLOOD

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial

(2010) Anthony V Moorman et al.   LANCET ONCOLOGY

Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells

(2010) Kwong-Lam Fung et al.   LEUKEMIA & LYMPHOMA

Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

(2009) Ching-Hon Pui et al.   NEW ENGLAND JOURNAL OF MEDICINE

Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival

(2008) Erik Forestier et al.   BRITISH JOURNAL OF HAEMATOLOGY

Prospective Analysis ofTELGene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

(2008) Jeffrey E. Rubnitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Asparaginase May Influence Dexamethasone Pharmacokinetics in Acute Lymphoblastic Leukemia

(2008) Lei Yang et al.   JOURNAL OF CLINICAL ONCOLOGY